DK2577A - Fremgangsmade til fremstilling af prostaglandinanaloge - Google Patents

Fremgangsmade til fremstilling af prostaglandinanaloge

Info

Publication number
DK2577A
DK2577A DK2577A DK2577A DK2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A
Authority
DK
Denmark
Prior art keywords
innalogue
prostagland
procedure
prostagland innalogue
innalogue procedure
Prior art date
Application number
DK2577A
Other languages
English (en)
Other versions
DK146025B (da
DK146025C (da
Inventor
M Hayashi
S Kori
H Wakatsuka
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/646,316 external-priority patent/US4052512A/en
Priority claimed from GB1598276A external-priority patent/GB1540427A/en
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK2577A publication Critical patent/DK2577A/da
Priority to DK255780A priority Critical patent/DK146202C/da
Publication of DK146025B publication Critical patent/DK146025B/da
Application granted granted Critical
Publication of DK146025C publication Critical patent/DK146025C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK2577A 1976-01-05 1977-01-04 Analogifremgangsmaade til fremstilling af trans-delta2-prostaglandinanaloge DK146025C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK255780A DK146202C (da) 1976-01-05 1980-06-13 Trans-delta2-prostaglandinanaloge og materiale indeholdende disse til brug som antifertilitetsmidler og andre ikke-medicinske formaal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64631676 1976-01-05
US05/646,316 US4052512A (en) 1976-01-05 1976-01-05 Prostaglandin analogues
GB1598276A GB1540427A (en) 1972-12-29 1976-04-20 Prostaglandin analogues
GB1598276 1976-04-20

Publications (3)

Publication Number Publication Date
DK2577A true DK2577A (da) 1977-07-06
DK146025B DK146025B (da) 1983-05-30
DK146025C DK146025C (da) 1983-10-24

Family

ID=26251676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK2577A DK146025C (da) 1976-01-05 1977-01-04 Analogifremgangsmaade til fremstilling af trans-delta2-prostaglandinanaloge

Country Status (6)

Country Link
JP (1) JPS5285151A (da)
AU (1) AU512644B2 (da)
DK (1) DK146025C (da)
IE (1) IE45491B1 (da)
LU (1) LU76513A1 (da)
NZ (1) NZ182968A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10494338B2 (en) 2016-05-09 2019-12-03 AGC Inc. Prostaglandin derivative
CN111263750B (zh) 2017-10-31 2022-02-25 Agc株式会社 前列腺素衍生物的制造方法

Also Published As

Publication number Publication date
NZ182968A (en) 1978-12-18
IE45491B1 (en) 1982-09-08
AU2104477A (en) 1978-07-13
JPS5285151A (en) 1977-07-15
LU76513A1 (da) 1977-07-14
DK146025B (da) 1983-05-30
AU512644B2 (en) 1980-10-23
JPS5761276B2 (da) 1982-12-23
IE45491L (en) 1977-07-05
DK146025C (da) 1983-10-24

Similar Documents

Publication Publication Date Title
DK13177A (da) Fremgangsmade til fremstilling af phthalaner
DK116177A (da) Fremgangsmade til fremstilling af hentriakontapeptider
DK81277A (da) Fremgangsmade til fremstilling af bis-pyridinium-forbindelser
DK323677A (da) Fremgangsmade til fremstilling af androstan-17-on-derivater
DK147777A (da) Fremgangsmade til fremstilling af acylchromaner
DK144177A (da) Fremgangsmade til fremstilling af acylayanider
DK153484C (da) Fremgangsmaade til fremstilling af gamma-pyroner
DK145877A (da) Fremgangsmade til immoblisering af glucoseisomerase
DK229877A (da) Fremgangsmade til bestemmelse af barbiturater
DK123277A (da) Fremgangsmade til fremstilling af 3-halogenmethyl-3-cephem-forbindelser
DK31977A (da) Fremgangsmade til fremstilling af chromanderivater
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK65877A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK420477A (da) Spaerreorgan til moentkanal
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK310777A (da) Fremgangsmade til fremstilling af guaiacol-p-isobutyl-hydratropat
DK428377A (da) Fremgangsmaade til fremstilling af pyridobenzodiazepinoner
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK73677A (da) Fremgangsmade til fremstilling af quinolinonderivater
SE7701143L (sv) Polumerisatinosforfarande
DK263577A (da) Fremgangsmade til fremstilling af substituerede 2-v-nyl-chromoner
DK88677A (da) Fremgangsmade til fremstilling af substituerede puriner
DK126577A (da) Fremgangsmade til fremstilling af n-propargylpiperonylamin

Legal Events

Date Code Title Description
PUP Patent expired